Higher rates of vaccination seen in older patients; lower rates seen for metastatic solid tumors, with comorbidities
Long COVID Seen in Most Cancer Patients After Infection
Other than female sex, no factors predict development of long-lasting symptoms
Pandemic-Linked Decline in Cancer Screening Persisted Into 2022
Low-dose computed tomographic scan rates and mammography rates below expected during March 2021 to February 2022
Inequities Seen in Cancer Treatment Delay in Patients With SARS-CoV-2
Race and ethnicity, area-level social determinants of health linked to delayed or discontinued cancer treatment
Risk for SARS-CoV-2 Breakthrough Infection Increased for Cancer Patients
Risk for severe outcomes of COVID-19 higher for patients with hematologic versus solid cancer
Mortality Disparities by Education Widened in the U.S. in 2020
Considerable increases in disparities seen for heart disease, cancer, cerebrovascular disease, unintentional injury mortality from 2019 to 2020
Fourth Vaccination Ups Immunity to Omicron Variants in Cancer Patients
Humoral response seen in patients receiving B cell-targeted therapy for hematologic malignancy, patients with solid malignancies
Uninsured Rate Did Not Change in 2020 for 18- to 64-Year-Olds
Prevalence of certain unhealthy behaviors decreased, while self-rated health improved, regardless of cancer history
COVID-19 Booster May Spur Seroconversion in Blood Cancer Patients
Among nonresponders to initial COVID-19 vaccination, seroconversion occurred in 56 percent following booster dose
Worldwide Drop in Cancer Screening Seen Early in Pandemic
Significant drops in cancer screening observed for several types of cancer